CTRI/2023/04/052096
Not yet recruiting
Phase 3
A double blind randomised placebo controlled clinical trial for evaluating the efficacy of Eranda Patra Ksharaand Hingu churna along with lifestyle modification in the management of Non-alcoholic fatty liver disease
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- All India Institute of Ayurveda
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Non\-alcoholic fatty liver disease
Exclusion Criteria
- •1\.The ratio of AST/ALT over 2
- •2\.Metabolic syndrom such as uncontrolled Type 1 and Type 2 diabetes mellitus,hypertension
- •3\.Thyroid dysfunction hyperthyroidism or hypothyroidism.
- •4\.Alcoholic fatty liver disease patient
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Clinical and physiological evaluation of a Chinese herbal medicine for constipation-predominant Irritable Bowel Syndrome (C-IBS Trial).Constipation-predominant Irritable Bowel SyndromeAlternative and Complementary Medicine - Herbal remediesACTRN12609000558224niversity of Western Sydney160
Completed
Not Applicable
A randomised placebo controlled double blind clinical trial of vitamin D in the treatment of tuberculosisTuberculosisInfections and InfestationsISRCTN35212132Bandim Health Project (Guinea-Bissau)500
Completed
Not Applicable
A randomised placebo controlled double blind clinical trial comparing selenium and pentoxifylline in patients with mild Graves' orbitopathy - EUGOGO study BISRCTN16320108Academic Medical Centre (AMC) (The Netherlands)156
Completed
Phase 2
Complementary and Alternative Medicine and the menopausal transition: The effect of a Chinese Herbal Formula on Vasomotor symptoms and bone turnover.ACTRN12608000617369Global Therapeutics Pty Ltd90
Completed
Phase 3
Rituximab in patients with primary Sjögren's syndromeISRCTN65360827niversity of Leeds (UK)110